HOB Biotech Group Corp.,Ltd - 688656.SS - Fundamentals

Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Insider Tracker is here!

Try it now Watch the presentation

‌
‌

‌

Let's get started...

‌

Breakdown	2016 12/31	2017 12/31	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	112	146	201	259	222	318	320	394	402	398	405	📊
Revenue Growth (1Y)	--	+31.11%	+37.68%	+28.63%	-14.38%	+43.20%	+0.84%	+23.10%	+2.01%	-0.98%	+1.53%	📊
Revenue Growth (5Y)	--	--	--	--	+98.80%	+117.13%	+59.05%	+52.21%	+81.35%	+25.40%	+27.32%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	+256.99%	+262.46%	📊
Cost of Revenue	38	44	59	83	76	99	118	149	145	0	126	📊
Cost of Revenue Growth (1Y)	--	+15.55%	+33.52%	+39.85%	-7.65%	+28.99%	+19.88%	+26.48%	-2.85%	-100.00%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+99.25%	+122.43%	+99.70%	+80.60%	+89.99%	-100.00%	+28.02%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	-100.00%	+229.03%	📊
Gross Profit	73	102	142	176	145	219	202	245	257	0	170	📊
Gross Profit Growth (1Y)	--	+39.26%	+39.48%	+23.97%	-17.54%	+50.67%	-7.71%	+21.13%	+4.98%	-100.00%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	+98.56%	+114.83%	+42.14%	+38.89%	+76.81%	-100.00%	-22.50%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	-100.00%	+131.84%	📊
Operating Expenses	69	69	83	106	93	133	160	189	216	425	566	📊
Operating Expenses Growth (1Y)	--	+0.37%	+21.09%	+26.69%	-11.61%	+42.21%	+20.16%	+18.64%	+14.03%	+96.97%	+33.10%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+36.11%	+92.84%	+91.35%	+79.20%	+131.17%	+220.19%	+326.17%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	+519.75%	+724.88%	📊
Sell General Administrative	44	40	49	65	54	77	89	106	59	0	113	📊
Research and Development	23	20	24	25	24	32	39	47	46	0	31	📊
Other Income Expenses	1	0	-3	15	15	24	32	0	110	425	423	📊
EBITDA	11	34	59	89	84	125	86	99	89	-27	-264	📊
EBITDA Growth (1Y)	--	+204.00%	+72.03%	+50.61%	-6.11%	+49.51%	-30.86%	+14.27%	-9.89%	-129.99%	-890.45%	📊
EBITDA Growth (5Y)	--	--	--	--	+639.53%	+263.71%	+46.17%	+10.90%	+6.44%	-121.35%	-311.44%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	-336.04%	-2437.84%	📊
Depreciation and Amortization	5	8	10	14	17	26	38	40	45	0	17	📊
Operating Income	3	25	49	70	65	98	48	56	41	-27	-290	📊
Operating Income Growth (1Y)	--	+681.48%	+99.96%	+42.49%	-7.07%	+49.81%	-51.23%	+17.40%	-25.89%	-164.43%	-986.45%	📊
Operating Income Growth (5Y)	--	--	--	--	+1969.10%	+296.64%	-3.25%	-20.29%	-36.43%	-127.34%	-397.05%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	-947.47%	-9307.33%	📊
Interest Expense	2	2	2	1	2	1	2	3	3	0	1	📊
Pre Tax Income	4	25	47	74	65	99	46	57	41	25	30	📊
Tax Provision	-0	3	7	10	8	13	5	9	4	1	2	📊
NET INCOME	4	21	40	64	57	86	42	47	37	23	28	📊
Net Income Growth (1Y)	--	+392.59%	+88.04%	+58.98%	-11.31%	+52.24%	-51.68%	+13.64%	-22.24%	-36.37%	+19.25%	📊
Net Income Growth (5Y)	--	--	--	--	+1206.06%	+303.64%	+3.73%	-25.86%	-35.00%	-72.83%	-67.60%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	+440.21%	+544.21%	📊
Basic EPS	0.1	0.47	0.88	1.01	0.9	1.37	0.66	0.75	0.59	0.37	0.43	📊
Diluted EPS	0.1	0.47	0.88	1.01	0.9	1.37	0.66	0.74	0.59	0.37	0.43	📊
Basic Average Shares	45	45	46	63	63	63	63	63	62	63	61	📊
Diluted Average Shares	45	45	46	63	63	63	63	64	63	63	61	📊

Breakdown

2016

12/31

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

112

146

201

259

222

318

320

394

402

398

405

📊

Revenue Growth (1Y)

+31.11%

+37.68%

+28.63%

-14.38%

+43.20%

+0.84%

+23.10%

+2.01%

-0.98%

+1.53%

📊

Revenue Growth (5Y)

+98.80%

+117.13%

+59.05%

+52.21%

+81.35%

+25.40%

+27.32%

📊

Revenue Growth (10Y)

+256.99%

+262.46%

📊

Cost of Revenue

118

149

145

126

📊

Cost of Revenue Growth (1Y)

+15.55%

+33.52%

+39.85%

-7.65%

+28.99%

+19.88%

+26.48%

-2.85%

-100.00%

📊

Cost of Revenue Growth (5Y)

+99.25%

+122.43%

+99.70%

+80.60%

+89.99%

-100.00%

+28.02%

📊

Cost of Revenue Growth (10Y)

-100.00%

+229.03%

📊

Gross Profit

102

142

176

145

219

202

245

257

170

📊

Gross Profit Growth (1Y)

+39.26%

+39.48%

+23.97%

-17.54%

+50.67%

-7.71%

+21.13%

+4.98%

-100.00%

📊

Gross Profit Growth (5Y)

+98.56%

+114.83%

+42.14%

+38.89%

+76.81%

-100.00%

-22.50%

📊

Gross Profit Growth (10Y)

-100.00%

+131.84%

📊

Operating Expenses

106

133

160

189

216

425

566

📊

Operating Expenses Growth (1Y)

+0.37%

+21.09%

+26.69%

-11.61%

+42.21%

+20.16%

+18.64%

+14.03%

+96.97%

+33.10%

📊

Operating Expenses Growth (5Y)

+36.11%

+92.84%

+91.35%

+79.20%

+131.17%

+220.19%

+326.17%

📊

Operating Expenses Growth (10Y)

+519.75%

+724.88%

📊

Sell General Administrative

106

113

📊

Research and Development

📊

Other Income Expenses

-3

110

425

423

📊

EBITDA

125

-27

-264

📊

EBITDA Growth (1Y)

+204.00%

+72.03%

+50.61%

-6.11%

+49.51%

-30.86%

+14.27%

-9.89%

-129.99%

-890.45%

📊

EBITDA Growth (5Y)

+639.53%

+263.71%

+46.17%

+10.90%

+6.44%

-121.35%

-311.44%

📊

EBITDA Growth (10Y)

-336.04%

-2437.84%

📊

Depreciation and Amortization

📊

Operating Income

-27

-290

📊

Operating Income Growth (1Y)

+681.48%

+99.96%

+42.49%

-7.07%

+49.81%

-51.23%

+17.40%

-25.89%

-164.43%

-986.45%

📊

Operating Income Growth (5Y)

+1969.10%

+296.64%

-3.25%

-20.29%

-36.43%

-127.34%

-397.05%

📊

Operating Income Growth (10Y)

-947.47%

-9307.33%

📊

Interest Expense

📊

Pre Tax Income

📊

Tax Provision

-0

📊

NET INCOME

📊

Net Income Growth (1Y)

+392.59%

+88.04%

+58.98%

-11.31%

+52.24%

-51.68%

+13.64%

-22.24%

-36.37%

+19.25%

📊

Net Income Growth (5Y)

+1206.06%

+303.64%

+3.73%

-25.86%

-35.00%

-72.83%

-67.60%

📊

Net Income Growth (10Y)

+440.21%

+544.21%

📊

Basic EPS

0.1

0.47

0.88

1.01

0.9

1.37

0.66

0.75

0.59

0.37

0.43

📊

Diluted EPS

0.1

0.47

0.88

1.01

0.9

1.37

0.66

0.74

0.59

0.37

0.43

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Breakdown	2016 12/31	2017 12/31	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	112	146	201	259	222	318	320	394	402	398	405	📊
Revenue Growth (1Y)	--	+31.11%	+37.68%	+28.63%	-14.38%	+43.20%	+0.84%	+23.10%	+2.01%	-0.98%	+1.53%	📊
Revenue Growth (5Y)	--	--	--	--	+98.80%	+117.13%	+59.05%	+52.21%	+81.35%	+25.40%	+27.32%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	+256.99%	+262.46%	📊
Cost of Revenue	38	44	59	83	76	99	118	149	145	0	126	📊
Cost of Revenue Growth (1Y)	--	+15.55%	+33.52%	+39.85%	-7.65%	+28.99%	+19.88%	+26.48%	-2.85%	-100.00%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+99.25%	+122.43%	+99.70%	+80.60%	+89.99%	-100.00%	+28.02%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	-100.00%	+229.03%	📊
Gross Profit	73	102	142	176	145	219	202	245	257	0	170	📊
Gross Profit Growth (1Y)	--	+39.26%	+39.48%	+23.97%	-17.54%	+50.67%	-7.71%	+21.13%	+4.98%	-100.00%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	+98.56%	+114.83%	+42.14%	+38.89%	+76.81%	-100.00%	-22.50%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	-100.00%	+131.84%	📊
Operating Expenses	69	69	83	106	93	133	160	189	216	425	566	📊
Operating Expenses Growth (1Y)	--	+0.37%	+21.09%	+26.69%	-11.61%	+42.21%	+20.16%	+18.64%	+14.03%	+96.97%	+33.10%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+36.11%	+92.84%	+91.35%	+79.20%	+131.17%	+220.19%	+326.17%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	+519.75%	+724.88%	📊
Sell General Administrative	44	40	49	65	54	77	89	106	59	0	113	📊
Research and Development	23	20	24	25	24	32	39	47	46	0	31	📊
Other Income Expenses	1	0	-3	15	15	24	32	0	110	425	423	📊
EBITDA	11	34	59	89	84	125	86	99	89	-27	-264	📊
EBITDA Growth (1Y)	--	+204.00%	+72.03%	+50.61%	-6.11%	+49.51%	-30.86%	+14.27%	-9.89%	-129.99%	-890.45%	📊
EBITDA Growth (5Y)	--	--	--	--	+639.53%	+263.71%	+46.17%	+10.90%	+6.44%	-121.35%	-311.44%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	-336.04%	-2437.84%	📊
Depreciation and Amortization	5	8	10	14	17	26	38	40	45	0	17	📊
Operating Income	3	25	49	70	65	98	48	56	41	-27	-290	📊
Operating Income Growth (1Y)	--	+681.48%	+99.96%	+42.49%	-7.07%	+49.81%	-51.23%	+17.40%	-25.89%	-164.43%	-986.45%	📊
Operating Income Growth (5Y)	--	--	--	--	+1969.10%	+296.64%	-3.25%	-20.29%	-36.43%	-127.34%	-397.05%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	-947.47%	-9307.33%	📊
Interest Expense	2	2	2	1	2	1	2	3	3	0	1	📊
Pre Tax Income	4	25	47	74	65	99	46	57	41	25	30	📊
Tax Provision	-0	3	7	10	8	13	5	9	4	1	2	📊
NET INCOME	4	21	40	64	57	86	42	47	37	23	28	📊
Net Income Growth (1Y)	--	+392.59%	+88.04%	+58.98%	-11.31%	+52.24%	-51.68%	+13.64%	-22.24%	-36.37%	+19.25%	📊
Net Income Growth (5Y)	--	--	--	--	+1206.06%	+303.64%	+3.73%	-25.86%	-35.00%	-72.83%	-67.60%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	+440.21%	+544.21%	📊
Basic EPS	0.1	0.47	0.88	1.01	0.9	1.37	0.66	0.75	0.59	0.37	0.43	📊
Diluted EPS	0.1	0.47	0.88	1.01	0.9	1.37	0.66	0.74	0.59	0.37	0.43	📊
Basic Average Shares	45	45	46	63	63	63	63	63	62	63	61	📊
Diluted Average Shares	45	45	46	63	63	63	63	64	63	63	61	📊

Breakdown

2016

12/31

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

112

146

201

259

222

318

320

394

402

398

405

📊

Revenue Growth (1Y)

+31.11%

+37.68%

+28.63%

-14.38%

+43.20%

+0.84%

+23.10%

+2.01%

-0.98%

+1.53%

📊

Revenue Growth (5Y)

+98.80%

+117.13%

+59.05%

+52.21%

+81.35%

+25.40%

+27.32%

📊

Revenue Growth (10Y)

+256.99%

+262.46%

📊

Cost of Revenue

118

149

145

126

📊

Cost of Revenue Growth (1Y)

+15.55%

+33.52%

+39.85%

-7.65%

+28.99%

+19.88%

+26.48%

-2.85%

-100.00%

📊

Cost of Revenue Growth (5Y)

+99.25%

+122.43%

+99.70%

+80.60%

+89.99%

-100.00%

+28.02%

📊

Cost of Revenue Growth (10Y)

-100.00%

+229.03%

📊

Gross Profit

102

142

176

145

219

202

245

257

170

📊

Gross Profit Growth (1Y)

+39.26%

+39.48%

+23.97%

-17.54%

+50.67%

-7.71%

+21.13%

+4.98%

-100.00%

📊

Gross Profit Growth (5Y)

+98.56%

+114.83%

+42.14%

+38.89%

+76.81%

-100.00%

-22.50%

📊

Gross Profit Growth (10Y)

-100.00%

+131.84%

📊

Operating Expenses

106

133

160

189

216

425

566

📊

Operating Expenses Growth (1Y)

+0.37%

+21.09%

+26.69%

-11.61%

+42.21%

+20.16%

+18.64%

+14.03%

+96.97%

+33.10%

📊

Operating Expenses Growth (5Y)

+36.11%

+92.84%

+91.35%

+79.20%

+131.17%

+220.19%

+326.17%

📊

Operating Expenses Growth (10Y)

+519.75%

+724.88%

📊

Sell General Administrative

106

113

📊

Research and Development

📊

Other Income Expenses

-3

110

425

423

📊

EBITDA

125

-27

-264

📊

EBITDA Growth (1Y)

+204.00%

+72.03%

+50.61%

-6.11%

+49.51%

-30.86%

+14.27%

-9.89%

-129.99%

-890.45%

📊

EBITDA Growth (5Y)

+639.53%

+263.71%

+46.17%

+10.90%

+6.44%

-121.35%

-311.44%

📊

EBITDA Growth (10Y)

-336.04%

-2437.84%

📊

Depreciation and Amortization

📊

Operating Income

-27

-290

📊

Operating Income Growth (1Y)

+681.48%

+99.96%

+42.49%

-7.07%

+49.81%

-51.23%

+17.40%

-25.89%

-164.43%

-986.45%

📊

Operating Income Growth (5Y)

+1969.10%

+296.64%

-3.25%

-20.29%

-36.43%

-127.34%

-397.05%

📊

Operating Income Growth (10Y)

-947.47%

-9307.33%

📊

Interest Expense

📊

Pre Tax Income

📊

Tax Provision

-0

📊

NET INCOME

📊

Net Income Growth (1Y)

+392.59%

+88.04%

+58.98%

-11.31%

+52.24%

-51.68%

+13.64%

-22.24%

-36.37%

+19.25%

📊

Net Income Growth (5Y)

+1206.06%

+303.64%

+3.73%

-25.86%

-35.00%

-72.83%

-67.60%

📊

Net Income Growth (10Y)

+440.21%

+544.21%

📊

Basic EPS

0.1

0.47

0.88

1.01

0.9

1.37

0.66

0.75

0.59

0.37

0.43

📊

Diluted EPS

0.1

0.47

0.88

1.01

0.9

1.37

0.66

0.74

0.59

0.37

0.43

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Ex-Dividend date
Payment date
Annual Dividend	0.20 (CNY)
Dividend Yield	0.18%
Shareholders Yield	1.15%
Next Earnings	--
Market cap	7.12B (CNY)
EPS (TTM)	0.43 (CNY)
P/E (TTM)	264.19 (CNY)
Last Close	113.60

Next Earnings	--
Market cap	7.12B (CNY)
EPS (TTM)	0.43 (CNY)
P/E (TTM)	264.19 (CNY)
Last Close	113.60 (CNY)

Ex-Dividend date
Payment date
Annual Dividend	0.20 (CNY)
Dividend Yield	0.18%
Shareholders Yield	1.15%
Next Earnings	--
Market cap	7.12B (CNY)
EPS (TTM)	0.43 (CNY)
P/E (TTM)	264.19 (CNY)
Last Close	113.60

Next Earnings	--
Market cap	7.12B (CNY)
EPS (TTM)	0.43 (CNY)
P/E (TTM)	264.19 (CNY)
Last Close	113.60 (CNY)